<description>&lt;p&gt;When we first featured a guest discussing GLP-1 therapies, the public’s understanding of these drugs to treat obesity was still developing. In 2023, our expert was Dr. Jamy Ard, the then-incoming president of The Obesity Society. Even then, Dr. Ard was stressing that more choices would lower prices for consumers. We look back on that […]&lt;/p&gt;
&lt;p&gt;The post &lt;a href="https://www.mwmediagroup.org/2026/06/glp-1-therapies-where-weve-been-where-were-going/"&gt;GLP-1 Therapies: Where We’ve Been &amp; Where We’re Going&lt;/a&gt; appeared first on &lt;a href="https://www.mwmediagroup.org"&gt;Healthy Communities Online&lt;/a&gt;.&lt;/p&gt;</description>

Conversations on Health Care

Conversations on Health Care

GLP-1 Therapies: Where We’ve Been & Where We’re Going

JUN 18, 202629 MIN
Conversations on Health Care

GLP-1 Therapies: Where We’ve Been & Where We’re Going

JUN 18, 202629 MIN

Description

<p>When we first featured a guest discussing GLP-1 therapies, the public’s understanding of these drugs to treat obesity was still developing. In 2023, our expert was Dr. Jamy Ard, the then-incoming president of The Obesity Society. Even then, Dr. Ard was stressing that more choices would lower prices for consumers. We look back on that […]</p> <p>The post <a href="https://www.mwmediagroup.org/2026/06/glp-1-therapies-where-weve-been-where-were-going/">GLP-1 Therapies: Where We’ve Been & Where We’re Going</a> appeared first on <a href="https://www.mwmediagroup.org">Healthy Communities Online</a>.</p>